Raphael Pharma board member resigns; Zvi Laufer Laor appointed as director

Raphael Pharmaceutical Inc.

Dr. Igal Louria Hayon resigned from Board effective Aug 1, 2025; no disagreement; remains CTO.
On Aug 7, 2025, Board appointed Zvi Laufer Laor (age 73, lawyer) to fill vacancy.
Board determined Mr. Laufer qualified and independent under relevant securities laws.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.